An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Clinical trial NCT03029988 · TERMINATED
Trial details
- NCT number
- NCT03029988
- Sponsor
- Navidea Biopharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2018-09-24
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.